Navigation Links
Israel Makov Appointed Chairman of Sun Pharma Board
Date:5/29/2012

MUMBAI, May 29, 2012 /PRNewswire/ --

The Board of Directors of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) met today and announced appointment of Mr Israel Makov as Chairman of the Board.

Mr. Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd (2002-2007). He is among Israel's most respected corporate leaders, and is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals.

Speaking on the induction, Mr Dilip Shanghvi, Managing Director of Sun Pharma said "I welcome Mr Makov on behalf of the entire Board and the larger Sun Pharma team.  He is an exceptional leader with deep knowledge and experience in globalizing businesses successfully.  As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience."

On his appointment, Mr Makov said, "I am happy to accept the position of Chairman of the Board.  Sun Pharma is an exciting company poised for substantial global expansion and I look forward to working together with Dilip and his team in realizing their visionary goals."

Profile of Mr Israel Makov

Mr Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd.  He joined Teva in 1995 and led the company's global expansion, managing over 12 acquisitions - two of which were the largest M&A deals in the Israeli history at the time.  Under Mr Makov's leadership, Teva became the undisputed global leader in generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis.  Prior to joining Teva in 1995, Mr. Makov led a number of companies in various industries, and founded Israel's first biotech company, Interpharm which went public in the US as the first Israeli company in R&D stage.

Currently, Mr Israel Makov is Chairman of Given Imaging - the pioneer developer and world's leading provider of capsule endoscopy, Chairman of BIOLIGHT - a life sciences investment company, Chairman of Micromedic Technologies Ltd. - a cluster of companies engaged in cancer diagnostics, and Chairman of Eltav - the pioneer and world leader in wireless monitoring of industrial valves.  Until recently, Mr Makov was Chairman of Netafim - the global leader in smart irrigation solutions.  Among his other notable engagements: Mr. Makov is a member of the Board of Directors of the Israel National Nanotechnology Initiative; a member of the Executive Board & Management Committee of the Weizmann Institute of Science and on the Board of Governors of the Technion - Israel Institute of Technology.

Mr Israel Makov holds a B.Sc. in Agriculture and M. Sc in Economics from the Hebrew University, Jerusalem.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company.  It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.  In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at http://www.sunpharma.com.

Contacts

Uday Baldota
Tel +91-22-6645-5645, Xtn 605
Tel Direct +91-22-66455605
Mobile +91-98670-10529
E mail uday.baldota@sunpharma.com

Mira Desai
Tel +91-22-6645-5645, Xtn 606
Tel Direct +91-22-66455606
Mobile +91-98219-23797
E mail mira.desai@sunpharma.com



'/>"/>
SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
2. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
3. MGuard(TM) Coronary Stent System Approved in Israel
4. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
5. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
6. Supreme Court of Israel Rules in Favor of Sun Pharma
7. SAFC® Completes Expansion of High-Potency Fermentation Capabilities at Israel Site
8. Robotic Surgery Expert Dr. David Samadi, MD Travels to Israel to Perform a Live Robotic Prostatectomy
9. Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success
10. 2P2D Ltd. Announces the Appointment of Tovi Bachar, Former Managing Director of GE Healthcare Israel, as Director and Chairman
11. Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):